Welcome to Viesearch. We're a human-curated search engine and would love your feedback.
Join now Sign in Submit
797,637,639
Searches
3,688,718
Submissions
651,742
Sites
7,692
Categories
294,615
Editors
275,102
Contributors

Sites

Approved contributions by @ellaturner to the Viesearch index.

Companion Diagnostics Development Services Market Growth

Roots Analysis reports the companion diagnostics development services market is anticipated to grow at a CAGR of over 10%. These tests improve success rates of late-stage trials.

Cell Invasion and Migration Assays Market Report

Market research report examining the market for cell invasion and migration assays from 2022-2035 from Roots Analysis.

Soft Tissue Sarcoma Market Projected to Reach USD 420 Million by 2030

Roots Analysis projects the Soft Tissue Sarcoma market to exceed USD 420 Million by 2030, with a report focusing on Angiosarcoma, Chondrosarcoma, and Liposarcoma.

Contract Regulatory Affairs for Medical Devices Market Analysis

Roots Analysis provides a detailed study on the current landscape of contract service providers focused on regulatory affairs management for medical devices.

Request Sample - Cell Line Characterization & Cell Line Development Market, 2035

Cell line characterization & cell line development market is likely to grow from USD 2.71 bn in 2025 to USD 3.14 bn in 2025 and USD 8.38 bn by 2035, representing a CAGR of 11.5%.

Growth in Remote Patient Monitoring Market

This article discusses the growth of the remote patient monitoring market attributed to the COVID-19 pandemic and endorsement from regional governments.

Top Selling Biologics Market: Current Landscape and Future Potential

Features an extensive study of the current market landscape and future potential of top-selling biologics used for treating various disease indications.

Stem Cell Therapy Market Analysis

The stem cell therapy market has gained traction. There are multiple approved products and several companies are advancing their proprietary therapy candidates.

Patient Recruitment and Retention Services Market

An increasing demand for participants in clinical research studies has prompted drug/therapy developers to outsource patient recruitment to specialty service providers.

Cell & Gene Therapy Bioassay Services Market Analysis

Roots Analysis helps companies in the cell and gene therapy bioassay services field compare their capabilities and identify ways to gain a competitive edge.

Progressive Supranuclear Palsy (PSP): Research and Challenges

Progressive Supranuclear Palsy (PSP) is a debilitating disease that affects the neuroscience community. Over 2,000 research studies, but there is no cure.

Rising Need of Large Volume Wearable Injectors

The demand for large-volume wearable injectors is rising due to increased incidence of chronic diseases and novel drug delivery systems.

Soft Tissue Sarcoma Treatment: Market and Pipeline Review

Extensive report on marketed, clinical, and preclinical molecules for the treatment of soft tissue sarcoma is available.

CAR-T Cell Therapies Market by Target Indications

Cancer is a leading cause of death worldwide. CAR-T cell therapies offer treatment options, with newly diagnosed cancer cases anticipated to grow significantly.

Wearable Injectors Market Analysis

Roots Analysis provides market research on evolving dynamics of large volume wearable injectors and challenges of high volume formulations.

The Significant Potential of Gut Flora: Human Microbiome

Discover the significant potential of human microbiome and its beneficial microbial colonies, which have been known to co-exist in mutually beneficial relationships.

ADCs: The Excitement Continues to Build

So, another round of the World ADCs just concluded. With a stellar line up that included Alain Beck from Pierre Fabre, Thorsten Sperber from Immunomedics, Nicholas Choong form Seattle Genetics, Rakesh Dixit from BioNavigen, Trevor Hallam from Sutro…

rootsanalysis.com · Blogs · 5 years ago · Details

Cell Therapy Manufacturing Market to Reach USD 10 Billion by 2030

The cell therapy manufacturing market is expected to grow by over 20% annually, reaching nearly USD 10 billion by 2030. Increased interest from pharma stakeholders in cell therapies and outsourcing manufacturing operations are key drivers.